Arcus Biosciences
biopharmaceutical company
Press Enter · cited answer in seconds
0 sources
Financials
Self-reported XBRL data from 9 annual filings
Revenue
$33.00M
Net Income
-$353.00M
Assets
$1.14B
EPS (diluted)
$-3.29
■ Revenue ■ Net Income
Source: SEC EDGAR · latest 10-K filed 2025-12-31 · accession
0001724521-26-000009Arcus Biosciences
Summary
Arcus Biosciences is a public company[1].
Key Facts
- Arcus Biosciences's field of work was precision medicine[2].
- Arcus Biosciences's field of work was immuno-oncology[3].
- Arcus Biosciences's field of work was immunotherapy[4].
- Arcus Biosciences's instance of is recorded as public company[5].
- Arcus Biosciences's headquarters location is recorded as Hayward[6].
- Arcus Biosciences's stock exchange is recorded as New York Stock Exchange[7].
- Arcus Biosciences's industry is recorded as pharmaceutical industry[8].
- 2015 marks the founding of Arcus Biosciences[9].
- Arcus Biosciences's official website is recorded as https://arcusbio.com/[10].
Body
Founding
2015 marks the founding of Arcus Biosciences[9].
Operations
Arcus Biosciences's headquarters location is recorded as Hayward[6].
Industry
Arcus Biosciences's industry is recorded as pharmaceutical industry[8]. Fields of work include precision medicine[2], a medical model[11]; immuno-oncology[3], a medical specialty[12]; and immunotherapy[4], a type of medical treatment[13].
Ownership
Arcus Biosciences's stock exchange is recorded as New York Stock Exchange[7].